Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2007 Jul 21;13(27):3726-9.
doi: 10.3748/wjg.v13.i27.3726.

Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type

Affiliations
Comparative Study

Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type

Nebil Bal et al. World J Gastroenterol. .

Abstract

Aim: To investigate the correlation between ezrin expression and types of gastric carcinoma and clinico-pathological variables.

Methods: We examined ezrin protein expression in 75 gastric carcinoma (53 intestinal types of adenocarcinoma, 22 diffuse types of carcinoma) tissues by immunohistochemistry. The results were compared with clinicopathological parameters such as tumor type, grade of tumor, clinical stage, presence of metastatic lymph node, and depth of invasion.

Results: Ezrin immunostaining was positive in 43 cases (81.1%) of intestinal type and in 9 (40.9%) cases of diffuse type adenocarcinomas (P < 0.001). In gastric carcinomas, the expression of ezrin protein correlated with the status of H pylori and survival. There was no correlation between expression of ezrin with TNM stage and histological grade of gastric carcinomas (P > 0.05).

Conclusion: The low expression of ezrin implicates the loss of adhesion in diffuse carcinomas. Furthermore, overexpression of ezrin in carcinomas with H pylori infection may be a genuine specific pathway in which H pylori may cause/initiate gastric carcinoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Strong immuno-reactivity of ezrin in grade II intestinal type gastric adenocar-cinoma cells (IHC, x 200).
Figure 2
Figure 2
Cytoplasmic immunpositivity of ezrin in poorly differentiated gastric adenocarcinoma (IHC, x 200).
Figure 3
Figure 3
Negative staining in atypical cells for ezrin in diffuse type gastric carcinoma. Positive staining in normal gastric glands (IHC, x 200).

References

    1. Dransfield DT, Bradford AJ, Smith J, Martin M, Roy C, Mangeat PH, Goldenring JR. Ezrin is a cyclic AMP-dependent protein kinase anchoring protein. EMBO J. 1997;16:35–43. - PMC - PubMed
    1. Hunter KW. Ezrin, a key component in tumor metastasis. Trends Mol Med. 2004;10:201–204. - PubMed
    1. Yao X, Cheng L, Forte JG. Biochemical characterization of ezrin-actin interaction. J Biol Chem. 1996;271:7224–7229. - PubMed
    1. Pujuguet P, Del Maestro L, Gautreau A, Louvard D, Arpin M. Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol Biol Cell. 2003;14:2181–2191. - PMC - PubMed
    1. Ohtani K, Sakamoto H, Rutherford T, Chen Z, Kikuchi A, Yamamoto T, Satoh K, Naftolin F. Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer Lett. 2002;179:79–86. - PubMed

Publication types